Target intelligence / Profile preview

Cytokine induced apoptosis inhibitor 1 pseudogene (CIAPIN1P)

Target: CIAPIN1P
Molecular classification: Other (Pseudogene)

Overview

Cytokine induced apoptosis inhibitor 1 pseudogene (CIAPIN1P) is a human pseudogene derived from the parental CIAPIN1 gene, which encodes a protein involved in apoptosis inhibition. CIAPIN1P does not produce a functional protein and is generally not expressed. Like most pseudogenes, it is a remnant of genomic duplication or retrotransposition events. CIAPIN1P is sometimes referenced by the alias HsT2384. There is no evidence linking CIAPIN1P to disease, biomarker use, or direct biological function in humans. Its status is \"Approved\" as a pseudogene by nomenclature authorities but not as a therapeutic or druggable target[1][3][5][6].

Other names: HsT2384

Beyond the preview

Go deeper on Cytokine induced apoptosis inhibitor 1 pseudogene (CIAPIN1P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine induced apoptosis inhibitor 1 pseudogene (CIAPIN1P).

Explore the full profile